{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:04:32Z","timestamp":1789718672556,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.canep.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T02:24:08Z","timestamp":1540002248000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study"],"prefix":"10.1016","volume":"57","author":[{"given":"Kunhwa","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong Han","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Etzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jen","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2018.10.003_bib0005","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1158\/1055-9965.EPI-06-0414","article-title":"The epidemiology of second primary cancers","volume":"15","author":"Travis","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2018.10.003_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canep.2018.10.003_bib0015","series-title":"Cancer Facts & Figures 2016","author":"American Cancer Society","year":"2016"},{"key":"10.1016\/j.canep.2018.10.003_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2018.10.003_bib0025","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2018.10.003_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2018.10.003_bib0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1200\/JCO.2012.43.5966","article-title":"Phase II study of the MEK1\/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor","volume":"31","author":"Kim","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2018.10.003_bib0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.canep.2018.10.003_bib0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1464-410X.2006.06004.x","article-title":"Multiple primary malignancies in patients with renal-cell carcinoma: a national population-based cohort study","volume":"97","author":"Beisland","year":"2006","journal-title":"BJU Int."},{"key":"10.1016\/j.canep.2018.10.003_bib0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaad.2009.07.039","article-title":"Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study","volume":"62","author":"Spanogle","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.canep.2018.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s10552-013-0267-0","article-title":"Characteristics of patients diagnosed with both melanoma and renal cell cancer","volume":"24","author":"Abern","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"Suppl. 8","key":"10.1016\/j.canep.2018.10.003_bib0060","article-title":"Emerging immunotherapies for renal-cell carcinoma","volume":"23","author":"Escudier","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2018.10.003_bib0065","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1200\/JCO.2006.08.3774","article-title":"Immunotherapy for renal cell cancer","volume":"24","author":"Yang","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 10","key":"10.1016\/j.canep.2018.10.003_bib0070","doi-asserted-by":"crossref","first-page":"x104","DOI":"10.1093\/annonc\/mds321","article-title":"Advances and perspectives in immunotherapy of melanoma","volume":"23","author":"Schadendorf","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2018.10.003_bib0075","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/cncr.11348","article-title":"Multiple primary cancers of the ovary in the United States, 1992\u20131997","volume":"97","author":"Howe","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2018.10.003_bib0080","unstructured":"Surveillance Research Program. National Cancer Institute SEER*Stat software (seer.cancer.gov\/seerstat) version<8.1.5>."},{"key":"10.1016\/j.canep.2018.10.003_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-5573-5-7","article-title":"Methods for stratification of person-time and events \u2013 a prerequisite for Poisson regression and SIR estimation","volume":"5","author":"Rostgaard","year":"2008","journal-title":"Epidemiol. Perspect. Innov."},{"key":"10.1016\/j.canep.2018.10.003_bib0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199301000-00009","article-title":"Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Livermore National Laboratory","volume":"4","author":"Hiatt","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/j.canep.2018.10.003_bib0095","series-title":"SEER Cancer Registries, 2000","article-title":"New malignancies among cancer survivors","author":"Curtis","year":"1973"},{"key":"10.1016\/j.canep.2018.10.003_bib0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev.me.39.020188.000431","article-title":"Tumors of the immunocompromised patient","volume":"39","author":"Penn","year":"1988","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.canep.2018.10.003_bib0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015677","article-title":"Cancer in the transplant recipient","volume":"3","author":"Chapman","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.canep.2018.10.003_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2018.10.003_bib0115","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2018.10.003_bib0120","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/sj.onc.1206989","article-title":"Second cancers after radiotherapy: any evidence for radiation-induced genomic instability?","volume":"22","author":"Sigurdson","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canep.2018.10.003_bib0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1055-9965.EPI-06-1069","article-title":"Non-Hodgkin lymphoma secondary to cancer chemotherapy","volume":"16","author":"Krishnan","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2018.10.003_bib0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/02841869409121767","article-title":"Secondary malignancies following cancer chemotherapy","volume":"33","author":"Boffetta","year":"1994","journal-title":"Acta Oncol."},{"key":"10.1016\/j.canep.2018.10.003_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canep.2018.10.003_bib0140","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1002\/cncr.25562","article-title":"Characteristics of the coexistence of melanoma and renal-cell carcinoma","volume":"116","author":"Maubec","year":"2010","journal-title":"Cancer"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118304156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118304156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T13:01:47Z","timestamp":1547643707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782118304156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"alternative-id":["S1877782118304156"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2018.10.003","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}